TQC3721 inhaled suspension

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQC3721 inhaled suspension, covering 2025-09-10 to 2025-09-10. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease [Phase 3]

See pricing